|
|
| NTR2_RAT |
Ntsr2 |
Neurotensin receptor type 2 |
3.331e-16 |
1.00
|
| CCR2_MOUSE |
Ccr2 |
C-C chemokine receptor type 2 |
7.994e-66 |
0.34
|
| Q6P1E0_MOUSE |
Syk |
Tyrosine-protein kinase |
3.822e-30 |
0.33
|
| OPRX_RAT |
Oprl1 |
Nociceptin receptor |
2.595e-21 |
0.31
|
| VACHT_RAT |
Slc18a3 |
Vesicular acetylcholine transporter |
2.33e-19 |
0.34
|
| Q8WQX9_9TRYP |
PDEB1 |
Phosphodiesterase |
4.655e-18 |
0.37
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
6.514e-13 |
0.36
|
| CCR2_HUMAN |
CCR2 |
C-C chemokine receptor type 2 |
7.248e-13 |
0.36
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
2.472e-12 |
0.36
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
3.518e-12 |
0.36
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
4.631e-11 |
0.41
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
7.764e-11 |
0.35
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
9.648e-11 |
0.40
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
1.195e-10 |
0.32
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
3.721e-10 |
0.37
|
| VACHT_HUMAN |
SLC18A3 |
Vesicular acetylcholine transporter |
5.289e-10 |
0.31
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
6.836e-10 |
0.36
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
7.06e-09 |
0.32
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
3.381e-08 |
0.33
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
3.315e-07 |
0.35
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
5.013e-07 |
0.35
|
| SC6A3_MACFA |
SLC6A3 |
Sodium-dependent dopamine transporter |
5.904e-07 |
0.28
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
7.17e-07 |
0.38
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
1.649e-06 |
0.35
|
| DHI1_HUMAN |
HSD11B1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 |
2.448e-06 |
0.39
|